financetom
Business
financetom
/
Business
/
Pony AI plans HK$139 per-share pricing for Hong Kong listing, Bloomberg News reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pony AI plans HK$139 per-share pricing for Hong Kong listing, Bloomberg News reports
Nov 2, 2025 7:33 PM

Nov 2 (Reuters) - Chinese autonomous driving firm Pony

AI plans to price its Hong Kong listing at HK$139

($17.90) per share, Bloomberg News reported on Sunday, citing

people familiar with the matter.

Reuters could not immediately verify the report.

($1 = 7.7675 Hong Kong dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Enterprise To Acquire Piñon Midstream For $950 Million
BRIEF-Enterprise To Acquire Piñon Midstream For $950 Million
Aug 21, 2024
Aug 21 (Reuters) - Enterprise Products Partners LP ( EPD ) : * ENTERPRISE TO ACQUIRE PIÑON MIDSTREAM * ENTERPRISE PRODUCTS PARTNERS LP ( EPD ) - TO ACQUIRE PIÑON MIDSTREAM FOR $950 MILLION * ENTERPRISE PRODUCTS PARTNERS LP ( EPD ) - TRANSACTION FUNDED USING CASH AND BORROWINGS * ENTERPRISE PRODUCTS PARTNERS ( EPD ): DEAL TO GENERATE DISTRIBUTABLE...
EnviroGold Global Commissions Demonstration Plant, Provides Corporate Updates
EnviroGold Global Commissions Demonstration Plant, Provides Corporate Updates
Aug 21, 2024
07:29 AM EDT, 08/21/2024 (MT Newswires) -- EnviroGold Global ( ESGLF ) said Wednesday that it is commissioning a demonstration plant that would monetize valuable metals from mine waste and tailings. The company said it expects to commence processing customer tailings through the plant in the coming weeks. The plant, which it acquired from the Australian government, Commonwealth Scientific and...
Bristol-Myers Squibb Says US FDA Accepts Supplemental BLA for Unresectable Hepatocellular Carcinoma Treatment
Bristol-Myers Squibb Says US FDA Accepts Supplemental BLA for Unresectable Hepatocellular Carcinoma Treatment
Aug 21, 2024
07:33 AM EDT, 08/21/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Wednesday that the US Food and Drug Administration has accepted the company's supplemental Biologics License Application for Opdivo plus Yervoy to treat adult patients with unresectable hepatocellular carcinoma. The FDA's acceptance was based on the company's late-stage trial, which showed a statistically significant and clinically meaningful improvement...
Factbox-Airlines suspend flights as Middle East tensions rise
Factbox-Airlines suspend flights as Middle East tensions rise
Aug 21, 2024
(Reuters) -Concerns over a wider conflict in the Middle East have prompted international airlines to suspend flights to the region or to avoid affected air space. Below are some of the airlines that have adjusted services to and from the region: AEGEAN AIRLINES The Greek airline cancelled flights to and from Amman until Sep. 30, Beirut until Oct. 1 and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved